Why did CLB's Q4 2024 EPS fall short of forecasts?

Core Laboratories' (CLB) Q4 2024 EPS fell short of forecasts due to a combination of factors impacting its financial performance: 1. **Decrease in U.S. Onshore Well Completion Activity**: This decrease, influenced by recent E&P consolidations and weak natural gas prices, led to a reduction in the demand for Core's services, particularly in the Production Enhancement segment. As a result, the company's adjusted earnings per share (EPS) were lower than expected. 2. **Revenue Shortfall**: The company experienced a total revenue shortfall of $5.16 million in Q4 2024 compared to the previous quarter, which could indicate operational challenges or market conditions that affected revenue recognition. 3. **Geopolitical Conflicts and Weather Events**: Ongoing geopolitical conflicts in the Middle East and Russia-Ukraine created headwinds for revenue growth and operating margins. Additionally, weather events such as hurricanes in the Gulf of Mexico negatively impacted revenue and operating margins, causing delays in scheduled projects. In summary, Core Laboratories' Q4 2024 EPS fell short of forecasts due to a decrease in U.S. onshore well completion activity, revenue shortfall and geopolitical conflicts and weather events. |code|Ticker|Name|Date|Basic EPS|Estimate EPS|market_code| |---|---|---|---|---|---|---| |CLB|CLB.N|Core Laboratories|2024 Q1|0.07|0.2|169| |CLB|CLB.N|Core Laboratories|2024 Q2|0.19|0.21|169| |CLB|CLB.N|Core Laboratories|2024 Q3|0.25|0.28|169| |CLB|CLB.N|Core Laboratories|2024 Q4|0.1577|0.27|169| |code|Ticker|Name|Date|Total Revenue YoY|Total Revenue|market_code| |---|---|---|---|---|---|---| |CLB|CLB.N|Core Laboratories|2024 Q1|0.9980055470722055|1.29637E8|169| |CLB|CLB.N|Core Laboratories|2024 Q2|2.1082099764624926|1.30577E8|169| |CLB|CLB.N|Core Laboratories|2024 Q3|7.223379047892582|1.34397E8|169| |CLB|CLB.N|Core Laboratories|2024 Q4|0.8010295608766868|1.29237E8|169|